Shanghai Chest Hospital
Clinical trials sponsored by Shanghai Chest Hospital, explained in plain language.
-
New drug duo aims to wipe out lung cancer before surgery
Disease control Not yet recruitingThis study tests whether giving two drugs (SHR-A1811 and adebelimumab) before surgery can shrink or eliminate HER2-altered non-small cell lung cancer. About 40 adults with early-stage, resectable cancer will receive the combination, then have surgery to remove any remaining tumor…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 26, 2026 06:11 UTC
-
Double-barrel heart treatment may keep AFib away longer
Disease control Not yet recruitingThis study tests whether adding a nerve-blocking procedure (renal denervation) to a standard heart ablation (pulsed-field ablation) can better prevent early return of atrial fibrillation in 86 adults with persistent AFib. Participants will be followed for 90 days without antiarrh…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
Robotic scope could biopsy and burn lung nodules in one go
Disease control Not yet recruitingThis study will test whether a robot-assisted bronchoscope can safely take a tissue sample (biopsy) and then immediately destroy a suspicious lung nodule using heat (radiofrequency ablation) in a single procedure. About 76 adults with small, early-stage lung nodules who cannot or…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 26, 2026 06:07 UTC
-
Heart fat drug may boost ablation success in AF patients
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug typically used for diabetes, can help prevent atrial fibrillation from coming back after a heart procedure called catheter ablation. The trial includes 280 adults with persistent AF and increased fat around the heart, but without dia…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Could a common diabetes pill slow lung cancer?
Disease control Not yet recruitingThis study looks at whether adding an SGLT2 inhibitor (a diabetes drug) to standard cancer treatment can help people with both advanced lung cancer and type 2 diabetes live longer or keep their cancer from growing. About 200 adults will take either the SGLT2 inhibitor or other di…
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Could a blood pressure pill help lung cancer patients live longer?
Disease control Not yet recruitingThis study looks at whether a drug called sacubitril/valsartan, which is used for heart failure and high blood pressure, can help people with advanced lung cancer who also have high blood pressure. The goal is to see if it lowers the risk of death and heart problems. About 200 ad…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo therapy aims to shrink hard-to-treat thymic tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of the immunotherapy drug adebrelimab, chemotherapy, and radiation before surgery can shrink tumors in people with locally advanced thymic carcinoma. About 31 participants will receive 2-4 cycles of this neoadjuvant therapy, then surg…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for hard-to-treat lung cancer: targeted drug plus chemo enters trial
Disease control Not yet recruitingThis study tests a new drug called vebreltinib combined with standard chemotherapy as a first treatment for people with advanced non-small cell lung cancer that has a specific marker (MET overexpression) and no other treatable gene changes. The goal is to see if the combination c…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New mobile scanner aims to sharpen lung biopsy views
Diagnosis Not yet recruitingThis study tests a new mobile 4D CT scanner that creates 3D images during a lung biopsy procedure. It involves 50 adults with lung spots needing a biopsy. The goal is to see if this technology provides clearer, more accurate images to help doctors diagnose better.
Sponsor: Shanghai Chest Hospital • Aim: Diagnosis
Last updated May 26, 2026 06:00 UTC